Literature DB >> 17182686

CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.

Christof Geldmacher1, Jeffrey R Currier, Eva Herrmann, Antelmo Haule, Ellen Kuta, Francine McCutchan, Lilian Njovu, Steffen Geis, Oliver Hoffmann, Leonard Maboko, Carolyn Williamson, Deborah Birx, Andreas Meyerhans, Josephine Cox, Michael Hoelscher.   

Abstract

The importance of HLA class I-restricted CD8 T-cell responses in the control of human immunodeficiency virus (HIV) infection is generally accepted. While several studies have shown an association of certain HLA class I alleles with slower disease progression, it is not fully established whether this effect is mediated by HIV-specific CD8 T-cell responses restricted by these alleles. In order to study the influence of the HLA class I alleles on the HIV-specific CD8 T-cell response and on viral control, we have assessed HIV-specific epitope recognition, plasma viral load, and expression of HLA class I alleles in a cohort of HIV-seropositive bar workers. Possession of the HLA class I alleles B5801, B8101, and B0702 was associated with a low median viral load and simultaneously with a broader median recognition of Gag epitopes compared to all other HLA alleles (twofold increase) (P = 0.0035). We further found an inverse linear relationship between the number of Gag epitopes recognized and the plasma viral load (R = -0.36; P = 0.0016). Particularly, recognition of multiple epitopes within two regions of Gag (amino acids [aa] 1 to 75 and aa 248 to 500) was associated with the maintenance of a low steady-state viremia, even years after acute infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182686      PMCID: PMC1865944          DOI: 10.1128/JVI.01847-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.

Authors:  Christof Geldmacher; Jeffrey R Currier; Martina Gerhardt; Antelmo Haule; Leonard Maboko; Deborah Birx; Clive Gray; Andreas Meyerhans; Josephine Cox; Michael Hoelscher
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

2.  Sequence-based typing provides a new look at HLA-C diversity.

Authors:  S Turner; M E Ellexson; H D Hickman; D A Sidebottom; M Fernández-Viña; D L Confer; W H Hildebrand
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

3.  Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.

Authors:  Rosario Zuñiga; Aldo Lucchetti; Patricia Galvan; Shyla Sanchez; Carmen Sanchez; Ana Hernandez; Hugo Sanchez; Nicole Frahm; Caitlyn H Linde; Hannah S Hewitt; William Hildebrand; Marcus Altfeld; Todd M Allen; Bruce D Walker; Bette T Korber; Thomas Leitner; Jorge Sanchez; Christian Brander
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 4.  The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes.

Authors:  Tumelo Mashishi; Clive M Gray
Journal:  Clin Chem Lab Med       Date:  2002-09       Impact factor: 3.694

5.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.

Authors:  Bradley H Edwards; Anju Bansal; Steffanie Sabbaj; Janna Bakari; Mark J Mulligan; Paul A Goepfert
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.

Authors:  V Novitsky; P Gilbert; T Peter; M F McLane; S Gaolekwe; N Rybak; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.

Authors:  Otto O Yang; Phuong Thi Nguyen Sarkis; Ayub Ali; Jason D Harlow; Christian Brander; Spyros A Kalams; Bruce D Walker
Journal:  J Exp Med       Date:  2003-05-12       Impact factor: 14.307

10.  Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus.

Authors:  Rika Draenert; Todd M Allen; Yang Liu; Terri Wrin; Colombe Chappey; Cori L Verrill; Guillem Sirera; Robert L Eldridge; Matthew P Lahaie; Lidia Ruiz; Bonaventura Clotet; Christos J Petropoulos; Bruce D Walker; Javier Martinez-Picado
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  92 in total

1.  For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Authors:  Ma Luo; Christina A Daniuk; Tamsir O Diallo; Rupert E Capina; Joshua Kimani; Charles Wachihi; Makubo Kimani; Thomas Bielawny; Trevor Peterson; Mark G R Mendoza; Sandra Kiazyk; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

3.  The immune response to the RT181-189 epitope in HIV-1-infected patients is associated with viral sequence polymorphism flanking the epitope.

Authors:  Yovana Pacheco; Clotilde Allavena; Yannick Guilloux; Sandra M Mueller-Schmucker; Angela G Hueckelhoven; Elisabeth André-Garnier; François Cleon; Virginie Ferré; Audrey Rodallec; Eric Billaud; Thomas Harrer; François Raffi; Dorian McIlroy
Journal:  J Clin Immunol       Date:  2011-04-14       Impact factor: 8.317

4.  Transmission and long-term stability of compensated CD8 escape mutations.

Authors:  Arne Schneidewind; Zabrina L Brumme; Chanson J Brumme; Karen A Power; Laura L Reyor; Kristin O'Sullivan; Adrianne Gladden; Ursula Hempel; Thomas Kuntzen; Yaoyu E Wang; Cesar Oniangue-Ndza; Heiko Jessen; Martin Markowitz; Eric S Rosenberg; Rafick-Pierre Sékaly; Anthony D Kelleher; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

5.  HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers.

Authors:  Toshiyuki Miura; Chanson J Brumme; Mark A Brockman; Zabrina L Brumme; Florencia Pereyra; Brian L Block; Alicja Trocha; Mina John; Simon Mallal; P Richard Harrigan; Bruce D Walker
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

6.  Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.

Authors:  Francesco Marras; Elena Nicco; Federica Bozzano; Antonio Di Biagio; Chiara Dentone; Emanuele Pontali; Silvia Boni; Maurizio Setti; Giancarlo Orofino; Eugenio Mantia; Valentina Bartolacci; Francesca Bisio; Agostino Riva; Roberto Biassoni; Lorenzo Moretta; Andrea De Maria
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

7.  Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART.

Authors:  Alexander O Pasternak; Marlous L Grijsen; Ferdinand W Wit; Margreet Bakker; Suzanne Jurriaans; Jan M Prins; Ben Berkhout
Journal:  JCI Insight       Date:  2020-03-26

8.  Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.

Authors:  Christina F Thobakgale; Andrew Prendergast; Hayley Crawford; Nompumelelo Mkhwanazi; Danni Ramduth; Sharon Reddy; Claudia Molina; Zenele Mncube; Alasdair Leslie; Julia Prado; Fundi Chonco; Wendy Mphatshwe; Gareth Tudor-Williams; Prakash Jeena; Natasha Blanckenberg; Krista Dong; Photini Kiepiela; Hoosen Coovadia; Thumbi Ndung'u; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.

Authors:  Adriana Weinberg; Ruth Dickover; Paula Britto; Chengcheng Hu; Julie Patterson-Bartlett; Joyce Kraimer; Howard Gutzman; William T Shearer; Mobeen Rathore; Ross McKinney
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

10.  Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Authors:  Gabriela Turk; Yanina Ghiglione; Juliana Falivene; María Eugenia Socias; Natalia Laufer; Romina Soledad Coloccini; Ana María Rodriguez; María Julia Ruiz; María Ángeles Pando; Luis David Giavedoni; Pedro Cahn; Omar Sued; Horacio Salomon; María Magdalena Gherardi
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.